Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effect of Nurse-Led Remote Monitoring and Patient Navigation on Psychological Distress and Self-Management (remote monitor)

17. november 2026 oppdatert av: doaa mansour ali, Cairo University

Effect of Nurse-Led Remote Monitoring and Patient Navigation on Psychological Distress and Self-Management Among Patients With Diabetes Mellitus

Diabetes mellitus is a chronic condition that often imposes significant psychological distress and requires complex daily self-management. This randomized controlled trial aims to evaluate the effectiveness of a structured nurse-led intervention combined with patient navigation on reducing psychological distress and improving self-management behaviors among patients with diabetes. Eligible adult patients with diabetes will be randomly assigned into either an intervention group receiving the nurse-led educational, psychosocial, and navigation support program alongside routine care, or a control group receiving routine diabetes care alone. Outcomes related to diabetes-related psychological distress and self-care adherence will be assessed at baseline and following the intervention period to determine the clinical impact of the program.

Studieoversikt

Status

Rekruttering

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

Background and Rationale:

Living with diabetes requires continuous lifestyle modifications, medication adherence, and blood glucose monitoring, which frequently lead to diabetes-related psychological distress, anxiety, and burnout. High levels of psychological distress negatively affect treatment adherence and glycemic control. Nurse-led interventions coupled with patient navigation offer a holistic, patient-centered approach by providing tailored health education, emotional support, problem-solving skills, and assistance in overcoming healthcare system barriers.

Study Objective:

The primary objective of this study is to examine the effect of a nurse-led intervention and patient navigation program on psychological distress and diabetes self-management among patients with diabetes.

Study Design and Methodology:

This study utilizes a two-arm, parallel-group randomized controlled trial (RCT) design. After obtaining informed consent and completing baseline assessments, eligible participants will be randomly allocated in a 1:1 ratio into two equal groups:

  1. Intervention Group: Participants will receive a structured nurse-led intervention and patient navigation program in addition to standard care. The intervention encompasses individualized diabetes self-management education, psychological and coping support, goal setting, care coordination, and regular follow-up reminders to facilitate access to healthcare services and address barriers to care.
  2. Control Group: Participants will continue to receive their standard routine diabetes care without the additional navigation or nurse-led sessions.

Outcome Assessment:

Both groups will be evaluated at baseline (pre-test) and after completion of the intervention (post-test) using validated psychometric and behavioral instruments measuring diabetes-related psychological distress (such as the Diabetes Distress Scale) and diabetes self-management practices (such as the Summary of Diabetes Self-Care Activities). Data will be statistically analyzed to compare pre- and post-intervention changes within and between the two study groups.

Studietype

Intervensjonell

Registrering (Antatt)

80

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

  • Navn: Doaa mansour Ali, assisstant professor
  • Telefonnummer: 01116240970
  • E-post: dodo8836@yahoo.com

Studiesteder

      • Cairo, Egypt
        • Rekruttering
        • The study will be conducted at the Diabetes and Endocrinology Outpatient Clinics of Helwan General Hospital, a major secondary-level governmental healthcare facility operating under the Ministry of Health and Population in Cairo, Egypt.
        • Ta kontakt med:
          • Doaa mansour Ali, assisstant professor
          • Telefonnummer: 01116240970
          • E-post: dodo8836@yahoo.com

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

Participants will be included in the study if they meet the following criteria:

  1. Adults aged 18 years or older.
  2. Patients with a confirmed diagnosis of type 1 or type 2 diabetes mellitus.
  3. Patients receiving routine diabetes care at the selected study setting.
  4. Patients who have access to a telephone or another suitable remote communication method.
  5. Patients who are willing to participate in the study and provide written informed consent.
  6. Patients who are able to understand and complete the study questionnaires in the selected validated language.
  7. Patients who are expected to be available throughout the intervention and follow-up period

Exclusion Criteria:

  1. Patients experiencing an acute medical condition requiring emergency treatment or hospitalization at the time of recruitment.
  2. Patients with severe cognitive impairment or communication difficulties that prevent meaningful participation in the intervention and completion of the assessment tools.
  3. Patients experiencing an acute psychiatric crisis requiring immediate specialized mental health intervention.
  4. Patients enrolled in another intensive remote diabetes-management program that could substantially overlap with the proposed intervention.
  5. Patients who decline participation or withdraw their informed consent. Note: A previous diagnosis of depression or anxiety should not automatically be an exclusion criterion unless justified by the study protocol. Including patients with stable mental health conditions may improve the applicability of the findings concerning psychological distress among diabetic patients.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Nurse led intervention and patient navigation

Participants will receive a nurse-led remote monitoring and patient navigation intervention aimed at supporting their psychological well-being and managing psychological distress over the intervention period.

Nurse-led remote monitoring and patient navigation: refers to a structured, eight-week intervention delivered by a trained community health nurse through scheduled telephone calls or other agreed remote communication methods. It includes reviewing patients' reported health status, reinforcing diabetes self-management education, identifying barriers to healthcare access, facilitating appointments and referrals, and coordinating follow-up with healthcare providers.

Ingen inngripen: Usual care group

Participants will receive usual care without the nurse-led remote monitoring and patient navigation intervention.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
changes in psychological distress
Tidsramme: 3 months

Assessment of changes in psychological distress among participants using the specified psychological distress assessment scale, comparing baseline and post-intervention measurements.

3 months
Change in Diabetes Self-Management
Tidsramme: 3 months

Assessment of changes in diabetes self-management among participants using the specified diabetes self-management assessment tool, comparing baseline and post-intervention measurements.

3 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Etterforskere

  • Hovedetterforsker: Doaa MANSOUR Ali, ASSISSTANT PROFESSOR, Cairo University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

12. oktober 2026

Primær fullføring (Faktiske)

12. oktober 2026

Studiet fullført (Antatt)

1. januar 2027

Datoer for studieregistrering

Først innsendt

12. november 2026

Først innsendt som oppfylte QC-kriteriene

17. november 2026

Først lagt ut (Faktiske)

19. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

19. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

17. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • HUNURSERC2026/10/67/14

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Individual participant data (IPD) collected during this study will not be shared with other researchers. The data will be used exclusively for the purposes of the current study and will be kept confidential to protect participants' privacy.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .